Edaravone protects against methylglyoxal-induced barrier damage in human brain endothelial cells.
Elevated level of reactive carbonyl species, such as methylglyoxal, triggers carbonyl stress and activates a series of inflammatory responses leading to accelerated vascular damage. Edaravone is the active substance of a Japanese medicine, which aids neurological recovery following acute brain ische...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4102474?pdf=render |
id |
doaj-d57f722b35fb49a4b4425a7384cebc2e |
---|---|
record_format |
Article |
spelling |
doaj-d57f722b35fb49a4b4425a7384cebc2e2020-11-25T02:33:34ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0197e10015210.1371/journal.pone.0100152Edaravone protects against methylglyoxal-induced barrier damage in human brain endothelial cells.Andrea E TóthFruzsina R WalterAlexandra BocsikPetra SánthaSzilvia VeszelkaLajos NagyLászló G PuskásPierre-Olivier CouraudFuyuko TakataShinya DohguYasufumi KataokaMária A DeliElevated level of reactive carbonyl species, such as methylglyoxal, triggers carbonyl stress and activates a series of inflammatory responses leading to accelerated vascular damage. Edaravone is the active substance of a Japanese medicine, which aids neurological recovery following acute brain ischemia and subsequent cerebral infarction. Our aim was to test whether edaravone can exert a protective effect on the barrier properties of human brain endothelial cells (hCMEC/D3 cell line) treated with methylglyoxal.Cell viability was monitored in real-time by impedance-based cell electronic sensing. The barrier function of the monolayer was characterized by measurement of resistance and flux of permeability markers, and visualized by immunohistochemistry for claudin-5 and β-catenin. Cell morphology was also examined by holographic phase imaging.Methylglyoxal exerted a time- and dose-dependent toxicity on cultured human brain endothelial cells: a concentration of 600 µM resulted in about 50% toxicity, significantly reduced the integrity and increased the permeability of the barrier. The cell morphology also changed dramatically: the area of cells decreased, their optical height significantly increased. Edaravone (3 mM) provided a complete protection against the toxic effect of methylglyoxal. Co-administration of edaravone restored cell viability, barrier integrity and functions of brain endothelial cells. Similar protection was obtained by the well-known antiglycating molecule, aminoguanidine, our reference compound.These results indicate for the first time that edaravone is protective in carbonyl stress induced barrier damage. Our data may contribute to the development of compounds to treat brain endothelial dysfunction in carbonyl stress related diseases.http://europepmc.org/articles/PMC4102474?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Andrea E Tóth Fruzsina R Walter Alexandra Bocsik Petra Sántha Szilvia Veszelka Lajos Nagy László G Puskás Pierre-Olivier Couraud Fuyuko Takata Shinya Dohgu Yasufumi Kataoka Mária A Deli |
spellingShingle |
Andrea E Tóth Fruzsina R Walter Alexandra Bocsik Petra Sántha Szilvia Veszelka Lajos Nagy László G Puskás Pierre-Olivier Couraud Fuyuko Takata Shinya Dohgu Yasufumi Kataoka Mária A Deli Edaravone protects against methylglyoxal-induced barrier damage in human brain endothelial cells. PLoS ONE |
author_facet |
Andrea E Tóth Fruzsina R Walter Alexandra Bocsik Petra Sántha Szilvia Veszelka Lajos Nagy László G Puskás Pierre-Olivier Couraud Fuyuko Takata Shinya Dohgu Yasufumi Kataoka Mária A Deli |
author_sort |
Andrea E Tóth |
title |
Edaravone protects against methylglyoxal-induced barrier damage in human brain endothelial cells. |
title_short |
Edaravone protects against methylglyoxal-induced barrier damage in human brain endothelial cells. |
title_full |
Edaravone protects against methylglyoxal-induced barrier damage in human brain endothelial cells. |
title_fullStr |
Edaravone protects against methylglyoxal-induced barrier damage in human brain endothelial cells. |
title_full_unstemmed |
Edaravone protects against methylglyoxal-induced barrier damage in human brain endothelial cells. |
title_sort |
edaravone protects against methylglyoxal-induced barrier damage in human brain endothelial cells. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2014-01-01 |
description |
Elevated level of reactive carbonyl species, such as methylglyoxal, triggers carbonyl stress and activates a series of inflammatory responses leading to accelerated vascular damage. Edaravone is the active substance of a Japanese medicine, which aids neurological recovery following acute brain ischemia and subsequent cerebral infarction. Our aim was to test whether edaravone can exert a protective effect on the barrier properties of human brain endothelial cells (hCMEC/D3 cell line) treated with methylglyoxal.Cell viability was monitored in real-time by impedance-based cell electronic sensing. The barrier function of the monolayer was characterized by measurement of resistance and flux of permeability markers, and visualized by immunohistochemistry for claudin-5 and β-catenin. Cell morphology was also examined by holographic phase imaging.Methylglyoxal exerted a time- and dose-dependent toxicity on cultured human brain endothelial cells: a concentration of 600 µM resulted in about 50% toxicity, significantly reduced the integrity and increased the permeability of the barrier. The cell morphology also changed dramatically: the area of cells decreased, their optical height significantly increased. Edaravone (3 mM) provided a complete protection against the toxic effect of methylglyoxal. Co-administration of edaravone restored cell viability, barrier integrity and functions of brain endothelial cells. Similar protection was obtained by the well-known antiglycating molecule, aminoguanidine, our reference compound.These results indicate for the first time that edaravone is protective in carbonyl stress induced barrier damage. Our data may contribute to the development of compounds to treat brain endothelial dysfunction in carbonyl stress related diseases. |
url |
http://europepmc.org/articles/PMC4102474?pdf=render |
work_keys_str_mv |
AT andreaetoth edaravoneprotectsagainstmethylglyoxalinducedbarrierdamageinhumanbrainendothelialcells AT fruzsinarwalter edaravoneprotectsagainstmethylglyoxalinducedbarrierdamageinhumanbrainendothelialcells AT alexandrabocsik edaravoneprotectsagainstmethylglyoxalinducedbarrierdamageinhumanbrainendothelialcells AT petrasantha edaravoneprotectsagainstmethylglyoxalinducedbarrierdamageinhumanbrainendothelialcells AT szilviaveszelka edaravoneprotectsagainstmethylglyoxalinducedbarrierdamageinhumanbrainendothelialcells AT lajosnagy edaravoneprotectsagainstmethylglyoxalinducedbarrierdamageinhumanbrainendothelialcells AT laszlogpuskas edaravoneprotectsagainstmethylglyoxalinducedbarrierdamageinhumanbrainendothelialcells AT pierreoliviercouraud edaravoneprotectsagainstmethylglyoxalinducedbarrierdamageinhumanbrainendothelialcells AT fuyukotakata edaravoneprotectsagainstmethylglyoxalinducedbarrierdamageinhumanbrainendothelialcells AT shinyadohgu edaravoneprotectsagainstmethylglyoxalinducedbarrierdamageinhumanbrainendothelialcells AT yasufumikataoka edaravoneprotectsagainstmethylglyoxalinducedbarrierdamageinhumanbrainendothelialcells AT mariaadeli edaravoneprotectsagainstmethylglyoxalinducedbarrierdamageinhumanbrainendothelialcells |
_version_ |
1724813122712109056 |